Synapse - Works

Results (53)

Phase Ib/II trial of the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, in combination with rituximab and lenalidomide in refractory/recurrent primary (PCNSL) and secondary central nervous system lymphoma (SCNSL)

Meeting Abstract

Grommes, C.; Piotrowski, A.; Pentsova, E.; Gavrilovic, I.; Stone, J. B.; Lin, A.; Wongchai, V.; Madzsar, J. T.; Malani, R.; Nolan, C.; more...
Blood (2022)

Fulltext@MSK | Save

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: An open-label, multi-center phase I study

Journal Article

Schaff, L. R.; Lobbous, M.; Carlow, D.; Schofield, R.; Gavrilovic, I. T.; Miller, A. M.; Stone, J. B.; Piotrowski, A. F.; Sener, U.; Skakodub, A.; more...
BMC Cancer (2022)

Fulltext@MSK | Save

The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors

Meeting Abstract

Coffee, E.; Panageas, K.; Young, R.; Morrison, T.; Daher, A.; Grommes, C.; Gavrilovic, I. T.; Lin, A.; Miller, A.; Schaff, L.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

Phase Ib trial with dose expansion of the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, in combination with rituximab and lenalidomide in patients with refractory/recurrent primary central nervous system lymphoma (PCNSL) and refractory/recurrent secondary central nervous system lymphoma (SCNSL)

Meeting Abstract

Grommes, C.; Piotrowski, A.; Pentsova, E.; Nolan, C.; Francis, J.; DeAngelis, L.; Schaff, L.; Mellinghoff, I. K.
Blood (2020)

Fulltext@MSK | Save

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

Journal Article

Kaley, T. J.; Panageas, K. S.; Pentsova, E. I.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I.; DeAngelis, L. M.; Abrey, L. E.; Holland, E. C.; Omuro, A.; more...
Annals of Clinical and Translational Neurology (2020)

Fulltext@MSK | Save

Letter: When less is more: Dexamethasone dosing for brain tumors

Correspondence

Lim-Fat, M. J.; Bi, W. L.; Lo, J.; Lee, E. Q.; Ahluwalia, M. S.; Batchelor, T. T.; Chang, S. M.; Chiocca, E. A.; Chukwueke, U.; Cloughesy, T. F.; more...
Neurosurgery (2019)

Fulltext@MSK | Save

Genomic correlates of disease progression and treatment response in prospectively characterized gliomas

Journal Article

Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

Journal Article

Kaley, T. J.; Panageas, K. S.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I. T.; DeAngelis, L. M.; Abrey, L. E.; Holland, E. C.; Lassman, A. B.
Journal of Neuro-Oncology (2019)

Fulltext@MSK | Save

Buparlisib in patients with recurrent glioblastoma harboring phosphatidylinositol 3-kinase pathway activation: An open-label, multicenter, multi-arm, phase II trial

Journal Article

Wen, P. Y.; Touat, M.; Alexander, B. M.; Mellinghoff, I. K.; Ramkissoon, S.; McCluskey, C. S.; Pelton, K.; Haidar, S.; Basu, S. S.; Gaffey, S. C.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Research Letter

Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
Nature Genetics (2019)

Fulltext@MSK | Save